4//SEC Filing
KENYON LAWRENCE A 4
Accession 0001209191-17-067229
CIK 0001649989other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 5:04 PM ET
Size
5.6 KB
Accession
0001209191-17-067229
Insider Transaction Report
Form 4
KENYON LAWRENCE A
CFO and Secretary
Transactions
- Sale
Common Stock
2017-12-22$1.13/sh−26,165$29,566→ 67,313 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
- [F2]Includes 43,478 shares of the Issuer's common stock subject to RSUs that will vest 50% on each of the third and fourth year anniversaries of the 9/15/15 grant date, subject to continued service through such date. The vesting of RSUs reported on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on December 22, 2016 was accelerated such that 100% of the shares underling those RSUs vested on December 21, 2017.
Documents
Issuer
Oncobiologics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001230484
Filing Metadata
- Form type
- 4
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 5:04 PM ET
- Size
- 5.6 KB